Single-Use Bioreactors

Published: 16-Apr-2012

19 - 20 June 2012
Conference
London, UK

This event will enable delegates to boost their understanding of how to manage multiple pipelines for nice biotherapeutic products; analyse case studies examining ROI and cost/benefit potential; manage a diverse supply chain and increase speed of r&d turnaround; find solutions to manage bench to full-scale production; expand production in rapidly growing BRIC economies; and discuss the creation of standardised connectivity across the industry

Organiser: Visiongain

Trending Articles

  1. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  2. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  3. Pharmapack Europe<font color="red"><sup><i>new dates</i></sup></font> 13–14 October 2021 | Conference | Paris, France
  4. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  5. Lab Innovations 30-31 October 2024 | Exhibition | Birmingham, UK

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Future drug success is all in the delivery

Today, the mode of delivery can play a huge part in drug choice and success, thus new delivery technologies are proving to be a lucrative draw for drug formulators in all therapy categories. Susan Birks reports on market progress and predicted growth in the various categories
Media

Strong growth in healthcare packaging market forecast

Visiongain predicts the global healthcare packaging market will reach a value of US$101.3bn in 2015 and will grow at a CAGR of 6.3% between 2015 and 2025
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Outsourcing demand keeps on growing

The move to outsource operations continues to rise as service offerings broaden beyond the traditional contract services, but the ability for service providers to make good margins remains difficult in this competitive market
Media

Biobanking market to reach US$24.4bn in 2017

Further growth expected over next decade, says Visiongain report
Media

New technologies to capture more than 10% of antibody therapeutics market by 2023

Led by antibody drug conjugates (ADCs), says Visiongain report
Media

Contract vaccine manufacturing market to reach $0.62bn in 2015, says report

With a drive towards cell based production methods
Media

Asia and Latin America will drive biosimilars growth in next decade, says Visiongain

Established players will focus on monoclonal antibodies and licensing deals
Subscribe now